but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment.
.
fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
. in washington before heading to baltimore for saturday's broadcast of
.